doi:10.13701/j.cnki.kqyxyj.2018.02.001

[1] Zhang ZC,Jacques E. Nör. The biology of head and neck cancer stem cells [J]. Oral Oncol,2012,48(1)∶1-9
[2] Clark J,Li W,Smith G,et al. Outcome of treatment for advanced cervical metastatic squamous cell carcinoma [J]. Head Neck,2005,27(2)∶87-94
[3] Argiris A,Karamouzis MV,Raben D,et al. Head and neck cancer [J]. The Lancet,2008,371(9625)∶1695-1709
[4] Ghuwalewala S,Ghatak D,Das P,et al. CD44(high)CD24(low) molecular signature determines the Cancer Stem Cell and EMT phenotype in Oral Squamous Cell Carcinoma [J]. Stem Cell Res,2016,16(2)∶405-417
[5] Prince ME,Zhou L,Moyer JS,et al. Evaluation of the immunogenicity of ALDH(high) human head and neck squamous cell carcinoma cancer stem cells in vitro [J]. Oral Oncol,2016,59∶30-42
[6] Tannishtha Reya SJM,Michael F. Clarke & Irving L,Weissman. Stem cells, cancer, and cancer stem cells [J]. Nature,2001,414(6859)∶105-111
[7] RitchieK. E NE. Perivascular stem cell niche in head and neck cancer [J]. Cancer Lett,2013,338(1)∶41-46
[8] Furth J,Kahn MC. The transmission of leukemia in mice with a single cell [J]. Am J Cancer,1937
[9] Lapidot T,Sirard C,Vormoor J,et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice [J]. Nature,1994,367(4)∶645-648
[10] Al Hajj M,Wicha MS,Benito Hernandez A,et al. Prospective identification of tumorigenic breast cancer cells [J]. Proc Natl Acad Sci U S A,2003,100(7)∶3983-3988
[11] Prince ME,Sivanandan R,Kaczorowski A,et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma [J]. Proc Natl Acad Sci U S A,2007,104(3)∶973-978
[12] Mery B,Guy JB,Espenel S,et al. Targeting head and neck tumoral stem cells: From biological aspects to therapeutic perspectives [J]. World J Stem Cells,2016,8(1)∶13-21
[13] Sudha Krishnamurthy ZD,Dmitry Vodopyanov,Atsushi Imai,et al. Endothelial cell-initiated signaling promotes the survival and self-renewal of cancer stem cells [J]. Cancer Res,2010,70(23)∶15
[14] Joshua B,Kaplan MJ,Doweck I,et al. Frequency of cells expressing CD44, a head and neck cancer stem cell marker: correlation with tumor aggressiveness [J]. Head Neck,2012,34(1)∶42-49
[15] de Jong MC,Pramana J,van der Wal JE,et al. CD44 expression predicts local recurrence after radiotherapy in larynx cancer [J]. Clin Cancer Res,2010,16(21)∶5329-5338
[16] McCord AM,Jamal M,Williams ES,et al. CD133+ glioblastoma stem-like cells are radiosensitive with a defective DNA damage response compared with established cell lines [J]. Clin Cancer Res,2009,15(16)∶5145-5153
[17] Zhang Q,Shi S,Yen Y,et al. A subpopulation of CD133(+) cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy [J]. Cancer Lett,2010,289(10)∶151-160
[18] Yuta Wakamatsu NS,Htoo Zarni Oo,Yutaka Naito,et al. Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer [J]. Pathology International,2012,62(2)∶8
[19] Sophos NA,Vasiliou V. Aldehyde dehydrogenase gene superfamily: the 2002 update [J]. Chemico-Biological Interactions,2003,143-144∶5-22
[20] Christophe Ginestier,Min Hee Hur,Emmanuelle Charafe-Jauffret,et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome [J]. Cell Stem Cell,2007,1(5)∶555-567
[21] Sullivan JP,Spinola M,Dodge M,et al. Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling [J]. Cancer Res,2010,70(23)∶9937-9948
[22] Chen YC,Chen YW,Hsu HS,et al. Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer [J]. Biochem Biophys Res Commun,2009,385(3)∶307-313
[23] Koichi Shimano MS,Atsuhito Okaya,Junichi Kitanaka,et al. Hepatic Oval Cells Have the Side Population Phenotype Defined by Expression of ATP-Binding Cassette Transporter ABCG2/BCRP1 [J]. American Journal of Pathology,2003,163(1)∶3-9
[24] Hadnagy A,Gaboury L,Beaulieu R,et al. SP analysis may be used to identify cancer stem cell populations [J]. Exp Cell Res,2006,312(19)∶3701-3710
[25] Bragado P,Estrada Y,Sosa MS,et al. Analysis of marker-defined HNSCC subpopulations reveals a dynamic regulation of tumor initiating properties [J]. PLoS One,2012,7(1)∶e29974
[26] Sun Q,Zhong Y,Wu F,et al. Immunotherapy using slow-cycling tumor cells prolonged overall survival of tumor-bearing mice [J]. BMC Med,2012,10∶172
[27] Spradling SJMaAC. Stem cells and niches: mechanisms that promote stem cell maintenance throughout life [J]. Cell,2008,132(4)∶27
[28] Calabrese C,Poppleton H,Kocak M,et al. A perivascular niche for brain tumor stem cells [J]. Cancer Cell,2007,11(1)∶69-82
[29] Simple M,Suresh A,Das D,et al. Cancer stem cells and field cancerization of oral squamous cell carcinoma [J]. Oral Oncol,2015,51(7)∶643-651
[30] Albini A,Bruno A,Gallo C,et al. Cancer stem cells and the tumor microenvironment: interplay in tumor heterogeneity [J]. Connect Tissue Res,2015,56(5)∶414-425
[31] Lee SW,Jeong HK,Lee JY,et al. Hypoxic priming of mESCs accelerates vascular-lineage differentiation through HIF1-mediated inverse regulation of Oct4 and VEGF [J]. EMBO Mol Med,2012,4(9)∶924-938
[32] Furuta E,Okuda H,Kobayashi A,et al. Metabolic genes in cancer: their roles in tumor progression and clinical implications [J]. Biochim Biophys Acta,2010,1805(2)∶141-152
[33] Keita Shibuya MO,Shuhei Suzuki,Manabu Seino,et al. Targeting the facilitative glucose transporter GLUT1 inhibits the self-renewal and tumor-initiating capacity of cancer stem cells [J]. Oncotarget,2014,6()∶11
[34] Zhang W,Chen H,Lv S,et al. High CD133 Expression Is Associated with Worse Prognosis in Patients with Glioblastoma [J]. Mol Neurobiol,2016,53(2)∶2354-2360
[35] Clevers H. The cancer stem cell: premises, promises and challenges [J]. Nat Med,2011,17(3)∶313-319
[36] Lee SH,Koo BS,Kim JM,et al. Wnt/beta-catenin signalling maintains self-renewal and tumourigenicity of head and neck squamous cell carcinoma stem-like cells by activating Oct4 [J]. J Pathol,2014,234(1)∶99-107
[37] Lee SH,Oh SY,Do SI,et al. SOX2 regulates self-renewal and tumorigenicity of stem-like cells of head and neck squamous cell carcinoma [J]. Br J Cancer,2014,111(11)∶2122-2130
[38] Jordi Codony-Servat,Rafael Rosell. Cancer stem cells and immunoresistance: clinical implications and solutions [J]. Transl Lung Cancer Res,2015,4(6)∶689-703
[39] Lang R, Patel D, Morris JJ, et al. Shaping gene expression in activated and resting primary macrophages by IL-10 [J]. J Immunol, 2002, 169∶2253-63
[40] Kortylewski M, Kujawski M, Wang T, et al. Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity [J]. Nat Med,2005,11∶1314-21
[41] Jin L,Hope KJ,Zhai Q,et al. Targeting of CD44 eradicates human acute myeloid leukemic stem cells [J]. Nat Med,2006,12(10)∶1167-1174
[42] Marion Gilormini,Céline Malesys,Emma Armandy,et al. Preferential targeting of cancer stem cells in the radiosensitizing effect of ABT-737 on HNSCC [J]. Oncotarget,2016,7(13)∶16731-16744
[43] Harrison H,Farnie G,Howell SJ,et al. Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor [J]. Cancer Res,2010,70(2)∶709-718
[44] Silvia Santamaria,Marisa Delgado,Leonor Kremer,et al. Will a mAb-Based Immunotherapy Directed against Cancer Stem Cells Be Feasible [J]. Front Immuol, 2017, 8∶1509
[45] Loebinger MR,Giangreco A,Groot KR,et al. Squamous cell cancers contain a side population of stem-like cells that are made chemosensitive by ABC transporter blockade [J]. Br J Cancer,2008,98(2)∶380-387
[46] Moreb JS, Ucar-Bilyeu DA, Khan A. Use of retinoic acid/aldehyde dehy-drogenase pathway as potential targeted therapy against cancer stem cells [J]. Cancer Chemother Pharmacol,2017,79(2)∶295-301
[47] Cimmino L, Dolgalev I, Wang Y, et al. Restoration of TET2 function blocks aberrant self-renewal and leukemia progression [J]. Cell,2017,170∶1079-95

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

[1]	ZOU Hai-xiao, YANG Hai-li, ZHAO Yi-fang, SONG Li. Effect and Mechanism of Propranolol on Proliferation, Migration, and Angiogenesis of Human Melanoma A375 cells [J]. Journal of Oral Science Research, 2018, 34(2): 139-143.
[2]	QIN Shuai-hua,LI Xin-ming,LI Wen-lu. Analysis of Influencing Factors of Life Quality of Patients with Oral Cancer after Reconstruction [J]. Journal of Oral Science Research, 2018, 34(2): 144-147.
[3]	DENG Xuan, YANG Fang. Influence of MUC1-siRNA on Migration, Invasion, and PI3K-Akt Signaling Pathway of Human Tongue Cancer Tca Cells [J]. Journal of Oral Science Research, 2018, 34(2): 148-151.
[4]	ZHANG Hou-hua, FAN Hua-li. Effect of Calpain 1 Gene Silencing by RNA Interference on Proliferation and Migration of Oral Squamous Cell Carcinoma Cell Lines HSC3 [J]. Journal of Oral Science Research, 2018, 34(2): 152-156.
[5]	WANG Li, LI Jian-guo. Sedative Effects of Dexmedetomidine for Patients Retained with Tracheal Intubation after Repair of Forearm Flap in Oral Cancer [J]. Journal of Oral Science Research, 2018, 34(2): 157-160.
[6]	LIU Yu-lan, MENG Lin, TANG Qi, BU Wen-huan, HUANG Guo-shuai, DAI Yi-bin, LIU Qi-lin, SUN Hong-chen. Ascorbic Acid Carbon Dots Kill Tongue Squamous Cell Carcinoma Cell by Promoting Autophagy [J]. Journal of Oral Science Research, 2018, 34(1): 35-38.
[7]	ZHOU Xiong-ming, NA Si-jia, PAN Shu-ting, QIU Jia-xuan. Effect of Plumbaginon on Invasion and Migration of Tongue Squamous Cell Carcinoma Cells and Its Mechanism [J]. Journal of Oral Science Research, 2018, 34(1): 39-43.
[8]	ZENG Guang,WEI Ke-wen.. Effect of MAP4K3-mTOR Signaling in Licochalcone A-induced Autophagy and Apoptosis of Human Oral Squamous Cell Carcinoma Cells. [J]. Journal of Oral Science Research, 2017, 33(12): 1241-1245.
[9]	XU Xiao-fang, JIA Xiao-wei, LIANG Li-zhong.. Expression of miR-30d in Tongue Squamous Cell Carcinoma and Effect of Antisense miR-30d on Cell Proliferation and Invasion. [J]. Journal of Oral Science Research, 2017, 33(12): 1262-1265.
[10]	ZHANG Hong-chao, LIU Yun-qing, SHAO Ming-jing, WANG Cui-ping, BI Liang-jia, MENG Pei-song.. Preliminary Study on Therapeutic Effect of AE-PDT on Tongue Squamous Cell Carcinoma in Nude Mice. [J]. Journal of Oral Science Research, 2017, 33(12): 1266-1269.
[11]	TANG Cai-jin, ZENG Qi-xin, FAGN Mei-fei, MA Fei, TAO Ren-Chuan, Niyukty Arjal. Curative Effect of Endogenous Resolvin D1 on Periodontitis in Rats [J]. Journal of Oral Science Research, 2017, 33(12): 1270-1273.
[12]	WU Chang-jing, WANG Wei-Lu, ZHEN En-ming, SHAO Jun.. Effect of YAP1 Small Interfering RNA on Biological Characteristics of Tongue Squamous Cell. [J]. Journal of Oral Science Research, 2017, 33(12): 1278-1281.
[13]	WU Li-bo, PAN Shu-ting, QIU Jia-xuan.. Expression Level and Clinical Efficacy of Multidrug Resistant Proteins before and after Neoadjuvant Chemotherapy in OSCC. [J]. Journal of Oral Science Research, 2017, 33(12): 1298-1301.
[14]	WANG Li-ping, GUO Xue-qi, YAN Yong-yong, ZHA Jun, CHEN Wei-hong, WEI Yong-xiang, ZHU Xin-xin, GUAN Hong-bing, GE Lin-hu. Effect and Functioanl Role of miR-146a in Oral Squamous Cell Carcinoma Tissues and Cell Lines [J]. Journal of Oral Science Research, 2017, 33(11): 1204-1208.
[15]	XU Fei, WANG Shan, MENG Yan, SHI Lei, QIANG Dong-xia, ZHAO Er-yang. Expression of SOX2 in OSCC and Its Correlation with EMT [J]. Journal of Oral Science Research, 2017, 33(11): 1209-1212.